SOURCE: National Comprehensive Cancer Network

National Comprehensive Cancer Network

September 30, 2014 10:13 ET

Cigna Using NCCN Content for Oncology Coverage Policy Development

As Part of the Company's Coverage Policy Development, Cigna Is Using the NCCN Guidelines(R) and the NCCN Compendium(R) as References in the Appropriate Choice for the Treatment of People With Cancer in the United States

FORT WASHINGTON, PA--(Marketwired - September 30, 2014) - Cigna is using National Comprehensive Cancer Network® (NCCN®) Content as a resource for oncology coverage policy development and updates for the company's more than 840,000 providers throughout the United States.

"Cigna recognizes the important role that NCCN has in establishing standards and guidance for care in the area of cancer screening, diagnosis, treatment, and surveillance," said Julie B. Kessel, MD, Cigna's Senior Medical Director for Coverage Policy.

As part of coverage policy development, Cigna uses the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), as well as the NCCN Drugs & Biologics Compendium (NCCN Compendium®), as references in the appropriate choice for the treatment of people with cancer in the United States.

"We applaud Cigna's decision to use the library of NCCN Guidelines and its derivatives as support for its oncology coverage policies," said Robert W. Carlson, MD, Chief Executive Officer, NCCN. "The collaboration between Cigna and NCCN benefits approximately 12.5 million members in the United States as it sets the framework for providers to deliver high-quality, evidence-based oncology care as defined by experts from the NCCN Member Institutions."

The NCCN Guidelines® are a comprehensive set of guidelines detailing the sequential management choices and interventions for 97 percent of malignant cancers. In addition, separate guidelines have been created related to major prevention and screening topics and a third set focuses on the major supportive care areas. The NCCN Guidelines provide recommendations based on the best evidence available at the time they are derived.

For more information about the NCCN Guidelines, visit

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.

Clinicians, visit Patients and caregivers, visit

About Cigna

Cigna Corporation (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Loyal American Life Insurance Company. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products including group life, accident and disability insurance. Cigna maintains sales capabilities in 30 countries and jurisdictions, and has approximately 85 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit

The following files are available for download:

Contact Information

  • Contact information
    Katie Kiley Brown, NCCN